全文获取类型
收费全文 | 4147篇 |
免费 | 349篇 |
国内免费 | 2篇 |
出版年
2023年 | 14篇 |
2022年 | 38篇 |
2021年 | 58篇 |
2020年 | 37篇 |
2019年 | 46篇 |
2018年 | 63篇 |
2017年 | 54篇 |
2016年 | 103篇 |
2015年 | 194篇 |
2014年 | 211篇 |
2013年 | 250篇 |
2012年 | 342篇 |
2011年 | 329篇 |
2010年 | 201篇 |
2009年 | 187篇 |
2008年 | 236篇 |
2007年 | 287篇 |
2006年 | 300篇 |
2005年 | 279篇 |
2004年 | 238篇 |
2003年 | 236篇 |
2002年 | 215篇 |
2001年 | 40篇 |
2000年 | 40篇 |
1999年 | 51篇 |
1998年 | 77篇 |
1997年 | 43篇 |
1996年 | 33篇 |
1995年 | 37篇 |
1994年 | 27篇 |
1993年 | 28篇 |
1992年 | 27篇 |
1991年 | 21篇 |
1990年 | 19篇 |
1989年 | 11篇 |
1988年 | 11篇 |
1987年 | 14篇 |
1986年 | 11篇 |
1985年 | 10篇 |
1984年 | 11篇 |
1983年 | 12篇 |
1982年 | 12篇 |
1981年 | 8篇 |
1979年 | 8篇 |
1978年 | 3篇 |
1977年 | 5篇 |
1967年 | 2篇 |
1966年 | 2篇 |
1962年 | 2篇 |
1961年 | 2篇 |
排序方式: 共有4498条查询结果,搜索用时 15 毫秒
941.
942.
Procaryotic Expression of Single-Chain Variable-Fragment (scFv) Antibodies: Secretion in L-Form Cells of Proteus mirabilis Leads to Active Product and Overcomes the Limitations of Periplasmic Expression in Escherichia coli 下载免费PDF全文
Jrg F. Rippmann Michaela Klein Christian Hoischen Bodo Brocks Wolfgang J. Rettig Johannes Gumpert Klaus Pfizenmaier Ralf Mattes Dieter Moosmayer 《Applied microbiology》1998,64(12):4862-4869
Recently it has been demonstrated that L-form cells of Proteus mirabilis (L VI), which lack a periplasmic compartment, can be efficiently used in the production and secretion of heterologous proteins. In search of novel expression systems for recombinant antibodies, we compared levels of single-chain variable-fragment (scFv) production in Escherichia coli JM109 and P. mirabilis L VI, which express four distinct scFvs of potential clinical interest that show differences in levels of expression and in their tendencies to form aggregates upon periplasmic expression. Production of all analyzed scFvs in E. coli was limited by the severe toxic effect of the heterologous product as indicated by inhibition of culture growth and the formation of insoluble aggregates in the periplasmic space, limiting the yield of active product. In contrast, the L-form cells exhibited nearly unlimited growth under the tested production conditions for all scFvs examined. Moreover, expression experiments with P. mirabilis L VI led to scFv concentrations in the range of 40 to 200 mg per liter of culture medium (corresponding to volume yields 33- to 160-fold higher than those with E. coli JM109), depending on the expressed antibody. In a translocation inhibition experiment the secretion of the scFv constructs was shown to be an active transport coupled to the signal cleavage. We suppose that this direct release of the newly synthesized product into a large volume of the growth medium favors folding into the native active structure. The limited aggregation of scFv observed in the P. mirabilis L VI supernatant (occurring in a first-order-kinetics manner) was found to be due to intrinsic features of the scFv and not related to the expression process of the host cells. The P. mirabilis L VI supernatant was found to be advantageous for scFv purification. A two-step chromatography procedure led to homogeneous scFv with high antigen binding activity as revealed from binding experiments with eukaryotic cells. 相似文献
943.
Werner W. Franke Hans Heid Ralf Zimbelmann Caecilia Kuhn Stefanie Winter-Simanowski Yvette Dörflinger Christine Grund Steffen Rickelt 《Cell and tissue research》2013,353(1):99-115
Protein PERP (p53 apoptosis effector related to PMP-22) is a small (21.4 kDa) transmembrane polypeptide with an amino acid sequence indicative of a tetraspanin character. It is enriched in the plasma membrane and apparently contributes to cell-cell contacts. Hitherto, it has been reported to be exclusively a component of desmosomes of some stratified epithelia. However, by using a series of newly generated mono- and polyclonal antibodies, we show that protein PERP is not only present in all kinds of stratified epithelia but also occurs in simple, columnar, complex and transitional epithelia, in various types of squamous metaplasia and epithelium-derived tumors, in diverse epithelium-derived cell cultures and in myocardial tissue. Immunofluorescence and immunoelectron microscopy allow us to localize PERP predominantly in small intradesmosomal locations and in variously sized, junction-like peri- and interdesmosomal regions (“tessellate junctions”), mostly in mosaic or amalgamated combinations with other molecules believed, to date, to be exclusive components of tight and adherens junctions. In the heart, PERP is a major component of the composite junctions of the intercalated disks connecting cardiomyocytes. Finally, protein PERP is a cobblestone-like general component of special plasma membrane regions such as the bile canaliculi of liver and subapical-to-lateral zones of diverse columnar epithelia and upper urothelial cell layers. We discuss possible organizational and architectonic functions of protein PERP and its potential value as an immunohistochemical diagnostic marker. 相似文献
944.
Daniel Neureiter Ralf Kemmerling Matthias Ocker Christoph Seidlhofer Viktoria Faber Markus St?cher Richard Greil Otto Dietze 《Journal of Hematopathology》2008,1(1):23-27
Our interesting case deals with the clinical and morphological aspects of a chronic neutrophilic leukemia and the critical evaluation of differential diagnosis of leukemoid reaction in bone marrow biopsies. 相似文献
945.
Maria Brandmann Michaela C. Hohnholt Charlotte Petters Ralf Dringen 《Neurochemical research》2014,39(5):883-892
Antiretroviral protease inhibitors are crucial components of the antiretroviral combination therapy that is successfully used for the treatment of patients with HIV infection. To test whether such protease inhibitors affect the glutathione (GSH) metabolism of neurons, cultured cerebellar granule neurons were exposed to indinavir, nelfinavir, lopinavir or ritonavir. In low micromolar concentrations these antiretroviral protease inhibitors did not acutely compromise the cell viability, but caused a time- and concentration-dependent increase in the accumulation of extracellular GSH which was accompanied by a matching loss in cellular GSH. The stimulating effect by indinavir, lopinavir and ritonavir on GSH export was immediately terminated upon removal of the protease inhibitors, while the nelfinavir-induced stimulated GSH export persisted after washing the cells. The stimulation of neuronal GSH export by protease inhibitors was completely prevented by MK571, an inhibitor of the multidrug resistance protein 1, suggesting that this transporter mediates the accelerated GSH export during exposure of neurons to protease inhibitors. These data suggest that alterations in brain GSH metabolism should be considered as potential side-effects of a treatment with antiretroviral protease inhibitors. 相似文献
946.
Ewan A. Langan Silvia Vidali Natascha Pigat Wolfgang Funk Erika Lisztes Tamás Bíró Vincent Goffin Christopher E. M. Griffiths Ralf Paus 《PloS one》2013,8(4)
Human scalp skin and hair follicles (HFs) are extra-pituitary sources of prolactin (PRL). However, the intracutaneous regulation of PRL remains poorly understood. Therefore we investigated whether well-recognized regulators of pituitary PRL expression, which also impact on human skin physiology and pathology, regulate expression of PRL and its receptor (PRLR) in situ. This was studied in serum-free organ cultures of microdissected human scalp HFs and skin, i.e. excluding pituitary, neural and vascular inputs. Prolactin expression was confirmed at the gene and protein level in human truncal skin, where its expression significantly increased (p = 0.049) during organ culture. There was, however, no evidence of PRL secretion into the culture medium as measured by ELISA. PRL immunoreactivity (IR) in female human epidermis was decreased by substance P (p = 0.009), while neither the classical pituitary PRL inhibitor, dopamine, nor corticotropin-releasing hormone significantly modulated PRL IR in HFs or skin respectively. Interferon (IFN) γ increased PRL IR in the epithelium of human HFs (p = 0.044) while tumour necrosis factor (TNF) α decreased both PRL and PRLR IR. This study identifies substance P, TNFα and IFNγ as novel modulators of PRL and PRLR expression in human skin, and suggests that intracutaneous PRL expression is not under dopaminergic control. Given the importance of PRL in human hair growth regulation and its possible role in the pathogenesis of several common skin diseases, targeting intracutaneous PRL production via these newly identified regulatory pathways may point towards novel therapeutic options for inflammatory dermatoses. 相似文献
947.
948.
949.